Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Immune System 'Killer' T-Cells May Not Be Key to Asthma

New study contradicts previous research, experts say

By Serena Gordon
HealthDay Reporter


Related Encyclopedia
 border=
Acne
Alagille Syndrome
Appendicitis
Asthma
More...

Related Healthscout Videos
 border=
What are your hopes for the future of research?
Video Interview: Dr. Atul Gawande on Why the Act of Writing is Essential 
Video Interview: Dr. Atul Gawande on the Benefits of Admitting Medical Errors
Video Interview: Dr. Atul Gawande on Candor and Medical Errors
More...

Related Animations
 border=
Asthma
Dental Cavities
More...

Related Drug Information
 border=
Adderal XR
Advair Diskus
Combivent
Concerta
More...

Related News Articles
 border=
Dads' Substance Use Hurts Expectant Moms' Efforts to Quit
Lung Capacity Declines Faster With Diabetes
Health Tip: Help Your Child's Cognitive Development
FDA Probing Possible Link Between Asthma Drug and Suicide Risk
More...

WEDNESDAY, April 4 (HealthDay News) -- While previous research suggested that a certain type of immune system cell -- called invariant natural killer T-cells -- might play a role in the development of asthma, a new study concludes that's just not the case.

In stark contrast to a previous study that found that these cells made up about 60 percent of the T-cells in an asthmatic's lungs, the current study found that fewer than 2 percent were invariant natural killer T-cells.

Text Continues Below



"We not only failed to find any evidence of raised counts of invariant natural killer T-cells in mild asthma and chronic obstructive pulmonary disorder but also failed to reproduce the observations [from past research] in moderate to severe disease," said one of the study's authors, Dr. Ratko Djukanovic, professor of respiratory medicine and director of Allergy and Inflammation Research at Southampton School of Medicine in the United Kingdom.

Djukanovic said he's not sure why this study found such low numbers of killer T-cells, but that improvements in the technology may have allowed his team to identify invariant natural killer T-cells with a higher degree of specificity.

Results of the study are published in the April 5 issue of the New England Journal of Medicine.

Asthma is a chronic lung disorder that causes symptoms such as wheezing, coughing and shortness of breath. About 20 million Americans have the lung disease and more than 4,000 people die of asthma complications each year, according to the U.S. Centers for Disease Control and Prevention.

Despite the disease's prevalence, the exact cause remains unknown. Health experts know that asthma can be triggered by a reaction to certain substances, such as dust mites, pollen or even cold air. It was commonly believed that exposure to allergens would cause the body to produce T-cells known as CD4+ helper T-cells, which would then release substances called cytokines that cause airway inflammation.

Page:  1 | 2 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 4/4/2007

Related Links
 border=
From Healthscout's partner site on genital herpes, HerpesConnection.com
Learn about genital herpes symptoms
What are herpes treatment options?
Get the details about herpes simplex 1 and 2.





New Features

New ADHD Site!

SOURCES: Ratko Djukanovic, M.D., professor, respiratory medicine, consultant respiratory physician and director of Allergy and Inflammation Research, division of Infection, Inflammation and Repair, Southampton School of Medicine and Southampton General Hospital, U.K.; Ricardo Vinuya, M.D., allergist and immunologist, private practice, Bingham Farms, and Providence Hospital and Medical Center, Southfield, Mich.; April 5, 2007, New England Journal of Medicine


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map